🇺🇸 FDA
Pipeline program

Lactobacillus rhamnosus F-1

CMUH112-REC1-161

Unknown other active

Quick answer

Lactobacillus rhamnosus F-1 for Allergic Rhinitis is a Unknown program (other) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
Allergic Rhinitis
Phase
Unknown
Modality
other
Status
active

Clinical trials